Detecting Drugs of Abuse Via Exhaled Breath Samples Using Differential Mobility Spectrometry
Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
This Phase II STTR program consists of two major goals within the overarching goal of
developing and validating a proprietary device (BID2) for marijuana and opioid detection in
breath samples.
Phase:
Phase 2
Details
Lead Sponsor:
Mclean Hospital
Collaborator:
Jacob Golde, VOX BIOMEDICAL LLC 42 Wiggins Ave Bedford, MA 017302348